Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, Craciun L, Ameye L, Veys I, Paesmans M, Larsimont D, Piccart-Gebhart M, Willard-Gallo K.

JCI Insight. 2019 Aug 13;5. pii: 129641. doi: 10.1172/jci.insight.129641.

2.

BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.

Solinas C, Marcoux D, Garaud S, Vitória JR, Van den Eynden G, de Wind A, De Silva P, Boisson A, Craciun L, Larsimont D, Piccart-Gebhart M, Detours V, t'Kint de Roodenbeke D, Willard-Gallo K.

Cancer Lett. 2019 May 28;450:88-97. doi: 10.1016/j.canlet.2019.02.027. Epub 2019 Feb 22.

PMID:
30797818
3.

Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.

Chi VLD, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, Gu-Trantien C, Krayem M, Duvillier H, Lodewyckx JN, Willard-Gallo K, Sibille C, Bron D.

BMC Cancer. 2019 Jan 17;19(1):81. doi: 10.1186/s12885-019-5276-2.

4.

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

De Silva P, Garaud S, Solinas C, de Wind A, Van den Eyden G, Jose V, Gu-Trantien C, Migliori E, Boisson A, Naveaux C, Duvillier H, Craciun L, Larsimont D, Piccart-Gebhart M, Willard-Gallo K.

EBioMedicine. 2019 Jan;39:226-238. doi: 10.1016/j.ebiom.2018.11.066. Epub 2018 Dec 20.

5.

Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer.

Garaud S, Zayakin P, Buisseret L, Rulle U, Silina K, de Wind A, Van den Eyden G, Larsimont D, Willard-Gallo K, Linē A.

Front Immunol. 2018 Nov 20;9:2660. doi: 10.3389/fimmu.2018.02660. eCollection 2018.

6.

Quantifying Tertiary Lymphoid Structure-Associated Genes in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissues.

Gu-Trantien C, Garaud S, Migliori E, Solinas C, Lodewyckx JN, Willard-Gallo K.

Methods Mol Biol. 2018;1845:139-157. doi: 10.1007/978-1-4939-8709-2_9.

PMID:
30141012
7.

Dropped gallstones mimicking peritoneal metastasis: A case report.

Garaud S, Stolz A.

Radiol Case Rep. 2018 Jun 30;13(4):878-881. doi: 10.1016/j.radcr.2018.05.017. eCollection 2018 Aug.

8.

Immunity drives TET1 regulation in cancer through NF-κB.

Collignon E, Canale A, Al Wardi C, Bizet M, Calonne E, Dedeurwaerder S, Garaud S, Naveaux C, Barham W, Wilson A, Bouchat S, Hubert P, Van Lint C, Yull F, Sotiriou C, Willard-Gallo K, Noel A, Fuks F.

Sci Adv. 2018 Jun 20;4(6):eaap7309. doi: 10.1126/sciadv.aap7309. eCollection 2018 Jun.

9.

Immune Infiltration in Invasive Lobular Breast Cancer.

Desmedt C, Salgado R, Fornili M, Pruneri G, Van den Eynden G, Zoppoli G, Rothé F, Buisseret L, Garaud S, Willard-Gallo K, Brown D, Bareche Y, Rouas G, Galant C, Bertucci F, Loi S, Viale G, Di Leo A, Green AR, Ellis IO, Rakha EA, Larsimont D, Biganzoli E, Sotiriou C.

J Natl Cancer Inst. 2018 Jul 1;110(7):768-776. doi: 10.1093/jnci/djx268.

10.

Immuno-oncology-101: overview of major concepts and translational perspectives.

Allard B, Aspeslagh S, Garaud S, Dupont FA, Solinas C, Kok M, Routy B, Sotiriou C, Stagg J, Buisseret L.

Semin Cancer Biol. 2018 Oct;52(Pt 2):1-11. doi: 10.1016/j.semcancer.2018.02.005. Epub 2018 Feb 8. Review.

PMID:
29428479
11.

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.

Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Risso P, Rodrigues Vitória J, Richard F, Migliori E, Noël G, Duvillier H, Craciun L, Veys I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K.

Front Immunol. 2017 Oct 30;8:1412. doi: 10.3389/fimmu.2017.01412. eCollection 2017.

12.

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.

Buisseret L, Pommey S, Allard B, Garaud S, Bergeron M, Cousineau I, Ameye L, Bareche Y, Paesmans M, Crown JPA, Di Leo A, Loi S, Piccart-Gebhart M, Willard-Gallo K, Sotiriou C, Stagg J.

Ann Oncol. 2018 Apr 1;29(4):1056-1062. doi: 10.1093/annonc/mdx730.

13.

DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.

Jeschke J, Bizet M, Desmedt C, Calonne E, Dedeurwaerder S, Garaud S, Koch A, Larsimont D, Salgado R, Van den Eynden G, Willard Gallo K, Bontempi G, Defrance M, Sotiriou C, Fuks F.

J Clin Invest. 2017 Aug 1;127(8):3090-3102. doi: 10.1172/JCI91095. Epub 2017 Jul 17.

14.

Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.

Buisseret L, Desmedt C, Garaud S, Fornili M, Wang X, Van den Eyden G, de Wind A, Duquenne S, Boisson A, Naveaux C, Rothé F, Rorive S, Decaestecker C, Larsimont D, Piccart-Gebhart M, Biganzoli E, Sotiriou C, Willard-Gallo K.

Mod Pathol. 2017 Sep;30(9):1204-1212. doi: 10.1038/modpathol.2017.43. Epub 2017 Jun 16.

15.

CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer.

Gu-Trantien C, Migliori E, Buisseret L, de Wind A, Brohée S, Garaud S, Noël G, Dang Chi VL, Lodewyckx JN, Naveaux C, Duvillier H, Goriely S, Larsimont D, Willard-Gallo K.

JCI Insight. 2017 Jun 2;2(11). pii: 91487. doi: 10.1172/jci.insight.91487. eCollection 2017 Jun 2.

16.

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials.

Solinas C, Ceppi M, Lambertini M, Scartozzi M, Buisseret L, Garaud S, Fumagalli D, de Azambuja E, Salgado R, Sotiriou C, Willard-Gallo K, Ignatiadis M.

Cancer Treat Rev. 2017 Jun;57:8-15. doi: 10.1016/j.ctrv.2017.04.005. Epub 2017 May 2. Review.

PMID:
28525810
17.

Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.

Buisseret L, Garaud S, de Wind A, Van den Eynden G, Boisson A, Solinas C, Gu-Trantien C, Naveaux C, Lodewyckx JN, Duvillier H, Craciun L, Veys I, Larsimont D, Piccart-Gebhart M, Stagg J, Sotiriou C, Willard-Gallo K.

Oncoimmunology. 2016 Dec 14;6(1):e1257452. doi: 10.1080/2162402X.2016.1257452. eCollection 2017.

18.

FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.

Garaud S, Roufosse F, De Silva P, Gu-Trantien C, Lodewyckx JN, Duvillier H, Dedeurwaerder S, Bizet M, Defrance M, Fuks F, Bex F, Willard-Gallo K.

Eur J Immunol. 2017 Jan;47(1):168-179. doi: 10.1002/eji.201646373. Epub 2016 Nov 30.

19.

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.

Garaud S, Taher TE, Debant M, Burgos M, Melayah S, Berthou C, Parikh K, Pers JO, Luque-Paz D, Chiocchia G, Peppelenbosch M, Isenberg DA, Youinou P, Mignen O, Renaudineau Y, Mageed RA.

Cell Mol Immunol. 2018 Feb;15(2):158-170. doi: 10.1038/cmi.2016.42. Epub 2016 Aug 8.

20.

Characterization of human breast cancer tissues by infrared imaging.

Verdonck M, Denayer A, Delvaux B, Garaud S, De Wind R, Desmedt C, Sotiriou C, Willard-Gallo K, Goormaghtigh E.

Analyst. 2016 Jan 21;141(2):606-19. doi: 10.1039/c5an01512j.

PMID:
26535413
21.

IRF5: a rheostat for tumor-infiltrating lymphocyte trafficking in breast cancer?

Garaud S, Willard-Gallo K.

Immunol Cell Biol. 2015 May-Jun;93(5):425-6. doi: 10.1038/icb.2015.39. No abstract available.

PMID:
26010613
22.

A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes.

Garaud S, Gu-Trantien C, Lodewyckx JN, Boisson A, De Silva P, Buisseret L, Migliori E, Libin M, Naveaux C, Duvillier H, Willard-Gallo K.

J Vis Exp. 2014 Dec 6;(94). doi: 10.3791/52392.

23.

Label-free phenotyping of peripheral blood lymphocytes by infrared imaging.

Verdonck M, Garaud S, Duvillier H, Willard-Gallo K, Goormaghtigh E.

Analyst. 2015 Apr 7;140(7):2247-56. doi: 10.1039/c4an01855a.

PMID:
25516910
24.

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.

Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, Le Buanec H, Sibille C, Manfouo-Foutsop G, Veys I, Haibe-Kains B, Singhal SK, Michiels S, Rothé F, Salgado R, Duvillier H, Ignatiadis M, Desmedt C, Bron D, Larsimont D, Piccart M, Sotiriou C, Willard-Gallo K.

J Clin Invest. 2013 Jul;123(7):2873-92. doi: 10.1172/JCI67428. Epub 2013 Jun 17.

25.

Lymphoproliferative disorders associated with hypereosinophilia.

Roufosse F, Garaud S, de Leval L.

Semin Hematol. 2012 Apr;49(2):138-48. doi: 10.1053/j.seminhematol.2012.01.003. Review.

PMID:
22449624
26.

CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte.

Mageed RA, Garaud S, Taher TE, Parikh K, Pers JO, Jamin C, Renaudineau Y, Youinou P.

Autoimmun Rev. 2012 Sep;11(11):795-8. doi: 10.1016/j.autrev.2012.02.007. Epub 2012 Feb 12. Review.

PMID:
22349614
27.

DNA methylation and B-cell autoreactivity.

Garaud S, Youinou P, Renaudineau Y.

Adv Exp Med Biol. 2011;711:50-60. Review.

PMID:
21627042
28.

CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.

Garaud S, Morva A, Lemoine S, Hillion S, Bordron A, Pers JO, Berthou C, Mageed RA, Renaudineau Y, Youinou P.

J Immunol. 2011 Apr 15;186(8):4835-44. doi: 10.4049/jimmunol.1003050. Epub 2011 Mar 11.

29.

IL-10 production by B cells expressing CD5 with the alternative exon 1B.

Garaud S, Le Dantec C, de Mendoza AR, Mageed RA, Youinou P, Renaudineau Y.

Ann N Y Acad Sci. 2009 Sep;1173:280-5. doi: 10.1111/j.1749-6632.2009.04616.x.

PMID:
19758163
30.

Autoreactive B cells and epigenetics.

Renaudineau Y, Garaud S, Le Dantec C, Alonso-Ramirez R, Daridon C, Youinou P.

Clin Rev Allergy Immunol. 2010 Aug;39(1):85-94. doi: 10.1007/s12016-009-8174-6. Review.

PMID:
19644775
31.

IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.

Garaud S, Le Dantec C, Jousse-Joulin S, Hanrotel-Saliou C, Saraux A, Mageed RA, Youinou P, Renaudineau Y.

J Immunol. 2009 May 1;182(9):5623-32. doi: 10.4049/jimmunol.0802412.

32.

Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes.

Garaud S, Le Dantec C, Berthou C, Lydyard PM, Youinou P, Renaudineau Y.

J Immunol. 2008 Aug 1;181(3):2010-8.

33.

Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.

Hillion S, Garaud S, Devauchelle V, Bordron A, Berthou C, Youinou P, Jamin C.

Immunology. 2007 Nov;122(3):371-80. Epub 2007 Jul 3.

Supplemental Content

Loading ...
Support Center